-
Partnering Contact Info
Partnering Contact Info
To contact Enzon with a collaborative opportunity please utilize the following business development contacts:
Email: partnering@enzon.com
Enzon Pharmaceuticals, Inc.
685 Route 202/206
Bridgewater, New Jersey 08807
Phone 908-541-8600
Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.85 | ||
| Change(%) |  | +0.04 | |
| Volume | 652143 | ||
| 4:42 PM - Mar 09, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
06-01-2009
Enzon Presents Clinical Data f...
Enzon Presents Clinical Data from HIF-1 Alpha Antagonist Study at ASCO
-- First specific HIF-1a inhibitor is well tolerated with early signs of clinical benefit-- -
04-23-2009
Enzon's Board of Directors Rea...
Enzon's Board of Directors Reaffirms Support of its Chairman and CEO
-
04-23-2009
Enzon Continues to Improve its...
Enzon Continues to Improve its Capital Structure
-- Company repurchased $17.5 million of its outstanding debt at a discount to par-- -
12-31-1969
Enzon Pharmaceuticals to Add N...
Enzon Pharmaceuticals to Add New Independent Director to Board
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
05-14-2009
UCB"s Cimzia® Approved in the...
UCB"s Cimzia® Approved in the U.S. for Adult Patients Suffering from Moderate to Severe Rheumatoid Arthritis
-- Enzon to receive royalties for PEGylation technology-- -
11-05-2008
Enzon Reports Solid Third Quar...
Enzon Reports Solid Third Quarter 2008 Results
-- Provides update on the sale of the specialty pharma business -- -
12-08-2008
Enzon Pharmaceuticals Commence...
Enzon Pharmaceuticals Commences Tender Offer For a Portion of its Debt